In this application, we propose to create a multi-disciplinary Center for Skin Stem Cell Biology based within the Department of Dermatology at the College of Physicians &Surgeons at Columbia University. This center will build on the existing research excellence within the Basic Science Research Group (BSRG) based in the Department of Dermatology that is dedicated to understanding the contributions of stem cells to the normal and abnormal growth ofthe skin, by defining their role in maintaining epithelial homeostasis, as well as the manner in which they contribute to the pathogenesis of disease states. The department has previously established an active and robust research program in the labs of six outstanding research investigators focused on two major themes related to keratinocyte biology: stem cells and skin cancer. We have identified two superb junior Faculty candidates, Drs. Valentina Greco and Elena Ezhkova, both of whom are post-doctoral fellows in the internationally renowned skin biology laboratory of Dr. Elaine Fuchs at the Rockefeller University. We have extended formal offers to these two candidates to join the Faculty ofthe Department of Dermatology with joint appointments in the Department of Pathology. We plan to utilize the resources provided by this PSO through NIAMS to support the recruitment of these two stellar junior faculty candidates in the next 12-18 months, in accordance with the ARRA guidelines. The addition of the research programs of Drs. Greco and Ezhkova will strengthen the stem cell component of our research programs, thereby enabling our Department to contribute to building a community of multidisciplinary researchers focusing on the challenge of enhancing current understanding ofthe basic biology of skin diseases. This initiative will permit these two truly outstanding investigators to be engrafted into our existing stem cell programs. They will be given the .intensive and sustained career development support needed to assure their maturation into independent investigators with their own peer-reviewed funding as part of the Center for Skin Stem Cell Biology at Columbia University.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
1P30AR058886-01
Application #
7859602
Study Section
Special Emphasis Panel (ZAR1-EHB-F (M2))
Program Officer
Baker, Carl
Project Start
2009-09-24
Project End
2011-08-31
Budget Start
2009-09-24
Budget End
2010-08-31
Support Year
1
Fiscal Year
2009
Total Cost
$651,042
Indirect Cost
Name
Columbia University (N.Y.)
Department
Dermatology
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Gurunathan, Sujatha; Winkles, Jeffrey A; Ghosh, Sankar et al. (2014) Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation. J Biol Chem 289:12976-88
Koblansky, A Alicia; Jankovic, Dragana; Oh, Hyunju et al. (2013) Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 38:119-30
Kang, Jung-Ah; Jeong, Sang Phil; Park, Daeho et al. (2013) Transition from heterotypic to homotypic PDK1 homodimerization is essential for TCR-mediated NF-?B activation. J Immunol 190:4508-15
Poligone, Brian; Hayden, Matthew S; Chen, Luojing et al. (2013) A role for NF-?B activity in skin hyperplasia and the development of keratoacanthomata in mice. PLoS One 8:e71887
Park, Sung-Gyoo; Long, Meixiao; Kang, Jung-Ah et al. (2013) The kinase PDK1 is essential for B-cell receptor mediated survival signaling. PLoS One 8:e55378
Hayden, Matthew S (2012) A less-canonical, canonical NF-?B pathway in DCs. Nat Immunol 13:1139-41
Mathur, Ramkumar; Oh, Hyunju; Zhang, Dekai et al. (2012) A mouse model of Salmonella typhi infection. Cell 151:590-602
Hayden, Matthew S; Ghosh, Sankar (2012) NF-?B, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26:203-34
Ghosh, Sankar; Hayden, Matthew S (2012) Celebrating 25 years of NF-?B research. Immunol Rev 246:5-13